LabOnline22h
Which blood test is best at monitoring ALS?
A new study compares three types of blood biomarkers: neurofilament light chain proteins, glial acidic proteins and phosphorylated tau 181.
QurAlis Announces Topline Data From its Phase 1 Clinical Trial of QRL-101 Evaluating Biomarkers of ALS and Epilepsy in Healthy Volunteers
QurAlis Corporation ("QurAlis"), a clinical-stage biotechnology company driving scientific breakthroughs into powerful precision medicines that have the potential to alter the trajectory of ...
Clene Demonstrates Strengthened ALS Survival Benefit with CNM-Au8® Treatment
Among participants who met the core RESTORE-ALS Trial criteria (e.g., baseline serum NfL > 33 pg/mL, TRICALS risk score range between –6.5 and –2.5, baseline slow vital capacity > 60%, and symptom ...
Cognixion Launches Clinical Trial for Late-Stage ALS to Deliver Conversation Level Communication with Adaptive AI-Driven Brain-Computer Interface
The study will measure the impact of Cognixion's novel combination of BCI, AI and AR technology on the ability of amyotrophic lateral sclerosis ...
Le Lézard11h
Eau Thermale Avène Launches Inaugural 'National Skin Barrier Day' on March 12th
Pierre Fabre Laboratories, the world's second largest dermo-cosmetics laboratory, continues its commitment to improving the quality of life of those with sensitive skin disorders with the launch of ...
Le Lézard11h
ASPCA Sees Increase in Number of Calls to Poison Control Center in 2024, Including Rise in Cases Related to Hallucinogenic Mushroom Consumption
In recognition of Poison Prevention Week (March 16-22, 2025), the ASPCA® (The American Society for the Prevention of Cruelty to Animals®) is releasing its annual list of top pet toxins encountered by ...